Treatment of Relapsed and Refractory T-Cell Lymphomas: First Pavlov State Medical University of Saint-Petersburg Experience

Hematological Oncology - United Kingdom
doi 10.1002/hon.152_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Gemcitabine Plus Liposomal Doxorubicin for Relapsed Refractory T-Cell Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Survival Benefit With Novel Agents in Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas (Ptcl): The Columbia University Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Astrometric Education in Saint-Petersburg State University, Russia

Proceedings of the International Astronomical Union
AstrophysicsAstronomyPlanetary ScienceSpace
2007English

Clinical Characteristics and Treatment Results of Pediatric Relapsed/Refractory Non-Hodgkin’s Lymphomas

Oncogematologiya
OncologyHematology
2018English

Environmental Innovative Activities in Saint - Petersburg State Technical University (SPbSTU))

Linnaeus Eco-Tech
2019English

Nelarabine Treatment in Adult Patients With Refractory/ Relapsed T-Cell Acute Lymphoblastic Leukaemia/Lymphoma: Experience of a Single Centre

Gematologiya i Transfuziologiya
Hematology
2019English

Case Series of Nivolumab Treatment in Patients With Relapsed/Refractory Hiv-Related Lymphomas

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Cd19-Directed Car T Cell Therapy (Ctl019) for Relapsed/Refractory Diffuse Large B-Cell and Follicular Lymphomas: Four Year Outcomes

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

G. F. Miller (Müller)—the First Archaeologist in Russia and the First Rector of Saint Petersburg University

Acta Baltica Historiae et Philosophiae Scientiarum
PhilosophyHistory
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy